| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NOVAVAX INC | President, R&D | Common Stock | 18,339 | $78,124 | $4.26 | 10 Mar 2023 | Direct |
| NOVAVAX INC | President, R&D | Restricted Stock Units | 12,596 | $71,671 | $5.69 | 10 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | 06 Mar 2023 | 6 | +$68,248 | 4 | President, R&D | 14 Mar 2023, 17:16 |
| NVAX | NOVAVAX INC | 14 Dec 2022 | 3 | -$17,799 | 4 | President, R&D | 16 Dec 2022, 16:01 |
| NVAX | NOVAVAX INC | 10 Mar 2022 | 2 | $0 | 4 | President, R&D | 14 Mar 2022, 19:45 |
| NVAX | NOVAVAX INC | 14 Dec 2021 | 18 | -$487,178 | 4 | President, R&D | 16 Dec 2021, 16:15 |
| NVAX | NOVAVAX INC | 07 Dec 2021 | 25 | -$1,246,221 | 4 | President, R&D | 09 Dec 2021, 16:20 |
| NVAX | NOVAVAX INC | 30 Nov 2021 | 20 | -$1,659,590 | 4 | President, R&D | 02 Dec 2021, 15:13 |
| NVAX | NOVAVAX INC | 26 Nov 2021 | 13 | -$582,969 | 4 | President, R&D | 30 Nov 2021, 16:06 |
| NVAX | NOVAVAX INC | 23 Nov 2021 | 10 | -$1,488,504 | 4 | President, R&D | 24 Nov 2021, 16:21 |
| NVAX | NOVAVAX INC | 15 Nov 2021 | 12 | -$1,399,434 | 4 | President, R&D | 17 Nov 2021, 16:25 |
| NVAX | NOVAVAX INC | 09 Nov 2021 | 10 | -$1,224,750 | 4 | President, R&D | 12 Nov 2021, 16:02 |
| NVAX | NOVAVAX INC | 02 Nov 2021 | 19 | -$1,359,142 | 4 | President, R&D | 04 Nov 2021, 17:22 |
| NVAX | NOVAVAX INC | 29 Oct 2021 | 6 | -$100,871 | 4 | President, R&D | 02 Nov 2021, 19:02 |
| NVAX | NOVAVAX INC | 26 Oct 2021 | 13 | -$1,287,881 | 4 | President, R&D | 28 Oct 2021, 17:09 |
| NVAX | NOVAVAX INC | 19 Oct 2021 | 12 | -$1,205,017 | 4 | President, R&D | 21 Oct 2021, 17:08 |
| NVAX | NOVAVAX INC | 15 Oct 2021 | 5 | -$156,278 | 4 | President, R&D | 19 Oct 2021, 17:04 |
| NVAX | NOVAVAX INC | 12 Oct 2021 | 8 | -$1,188,808 | 4 | President, R&D | 14 Oct 2021, 17:16 |
| NVAX | NOVAVAX INC | 05 Oct 2021 | 14 | -$1,281,485 | 4 | President, R&D | 07 Oct 2021, 17:18 |
| NVAX | NOVAVAX INC | 30 Sep 2021 | 8 | -$143,622 | 4 | President, R&D | 01 Oct 2021, 17:58 |
| NVAX | NOVAVAX INC | 29 Sep 2021 | 19 | -$625,760 | 4 | President, R&D | 29 Sep 2021, 17:08 |
| NVAX | NOVAVAX INC | 15 Sep 2021 | 14 | -$226,473 | 4 | President, R&D | 17 Sep 2021, 17:08 |
| NVAX | NOVAVAX INC | 31 Aug 2021 | 8 | -$332,463 | 4 | President, R&D | 01 Sep 2021, 17:23 |
| NVAX | NOVAVAX INC | 26 Aug 2021 | 18 | -$1,248,665 | 4 | President, R&D | 30 Aug 2021, 18:16 |
| NVAX | NOVAVAX INC | 16 Aug 2021 | 22 | -$359,924 | 4 | President, R&D | 18 Aug 2021, 17:26 |
| NVAX | NOVAVAX INC | 20 Jul 2021 | 18 | -$518,982 | 4 | President, R&D | 22 Jul 2021, 17:20 |
| NVAX | NOVAVAX INC | 15 Jul 2021 | 20 | -$1,310,034 | 4 | President, R&D | 19 Jul 2021, 19:52 |
| NVAX | NOVAVAX INC | 15 Jun 2021 | 27 | -$1,847,797 | 4 | President, R&D | 17 Jun 2021, 18:17 |
| NVAX | NOVAVAX INC | 17 May 2021 | 22 | -$1,306,906 | 4 | President, R&D | 19 May 2021, 17:26 |